International Flavors & Fragrances Inc.

(New York Stock Exchange)
Back to all articles
Bullish +55

International Flavors & Fragrances Q3 Earnings Call Highlights

Acquisition Dividend Earnings report AI-generated analysis

📈 IFF raised its lower-end guidance for 2026 sales to $7.5 billion–$7.6 billion and adjusted operating EBITDA to $1.55 billion–$1.6 billion following Q3 results.

💰 Third-quarter revenue grew approximately 5% on a comparable currency-neutral basis, while adjusted operating EBITDA rose 6% to $403 million.

🍫 Taste and Scent segments both posted 6% sales growth, with Taste reaching $687 million and Scent reaching $689 million in the quarter.

🧬 Health & Biosciences sales increased 1% to $566 million as growth in Food Biosciences offset a decline in the health category.

⚠️ Fourth-quarter profitability is expected to face pressure from softer health volumes, higher input costs, and seasonal factors.

🌍 Greater Asia led Taste segment growth with a double-digit increase, followed by high-single-digit growth in Latin America.

🏭 IFF remains on track to close its $4.3 billion Food Ingredients sale to CVC Capital Partners by the end of H1 2027.

💸 Free cash flow for the first nine months of the year rose to $371 million, reflecting improved operational efficiency.

📉 Net debt to adjusted EBITDA stood at 2.75 times at the end of Q3, up slightly due to an accelerated share repurchase.

🔧 The company plans to eliminate about two-thirds of the $100 million in stranded costs from the Food Ingredients separation within 12 months.

Bullish Signals
  • IFF raised its lower-end guidance for 2026 sales to $7.5 billion–$7.6 billion and adjusted operating EBITDA to $1.55 billion–$1.6 billion following strong Q3 performance.
  • Third-quarter revenue grew approximately 5% on a comparable currency-neutral basis, while adjusted operating EBITDA rose 6% to $403 million.
  • Both Taste and Scent segments achieved 6% sales growth in the quarter, with Taste reaching $687 million and Scent reaching $689 million.
  • Health & Biosciences segment sales increased 1% to $566 million as mid-single-digit growth in Food Biosciences offset a decline in health.
  • Greater Asia led Taste segment growth with a double-digit increase, followed by high-single-digit growth in Latin America.
  • Free cash flow for the first nine months of the year rose to $371 million, an increase of $245 million from a year earlier.
  • The company successfully completed a $500 million accelerated share repurchase, buying approximately 5.8 million shares.
Risk Factors
  • Fourth-quarter profit margins are expected to decline sequentially due to softer health volumes, higher input costs, and seasonal factors.
  • Health & Biosciences segment faces margin pressure from unfavorable pricing relative to input costs and timing of research investments.
  • Consumers in the U.S. and Europe have reduced spending on dietary supplements amid economic pressure, impacting the Health & Biosciences segment.
  • The gap between pricing and input costs is expected to be greatest in the first quarter of 2027 before improving through the year.
Full Analysis
International Flavors & Fragrances (IFF) raised its full-year 2026 outlook following a strong third quarter, projecting sales between $7.5 billion and $7.6 billion and adjusted operating EBITDA of $1.55 billion to $1.6 billion. The company reported third-quarter revenue growth of approximately 5% and an increase in adjusted operating EBITDA of 6%, driven by performance across its Taste, Scent, and Health & Biosciences segments. IFF's Taste segment saw sales rise 6% to $687 million, with significant contributions from Greater Asia and Latin America. The Scent segment also achieved 6% sales growth to $689 million, supported by new business wins in Europe and North America. However, the Health & Biosciences segment grew only 1% due to reduced consumer spending on dietary supplements in the U.S. and Europe. Looking ahead, IFF expects fourth-quarter margin pressure stemming from softer health volumes, higher input costs related to oil derivatives and energy, and seasonal factors. The company remains committed to closing its $4.3 billion sale of Food Ingredients by the end of the first half of 2027 and plans to eliminate approximately two-thirds of associated stranded costs within 12 months.